Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001610717-25-000365
Filing Date
2025-10-17
Accepted
2025-10-17 18:17:47
Documents
2
Period of Report
2025-08-01

Document Format Files

Seq Description Document Type Size
1 form3.html 3  
1 form3.xml 3 3762
2 poa.txt EX-24 5689
  Complete submission text file 0001610717-25-000365.txt   10913
Mailing Address 34175 ARDENWOOD BLVD. FREMONT CA 94555
Business Address 34175 ARDENWOOD BLVD. FREMONT CA 94555 510-745-7047
ARDELYX, INC. (Issuer) CIK: 0001437402 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 501 CANAL BLVD. POINT RICHMOND TECH CENTER RICHMOND CA 94804
Business Address
Conner Edward R. (Reporting) CIK: 0001691265 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36485 | Film No.: 251401859